{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:14:58Z","timestamp":1783487698482,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-022-03443-2","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T07:02:57Z","timestamp":1644822177000},"page":"1414-1424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Bladder paragangliomas: a pictorial review"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-844X","authenticated-orcid":false,"given":"Samuel J.","family":"Withey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-2196","authenticated-orcid":false,"given":"Davide","family":"Prezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Rottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Sit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahim","family":"Ul-Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Velusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Izatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey E. T.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"3443_CR1","doi-asserted-by":"publisher","first-page":"457.e459","DOI":"10.1016\/j.urolonc.2017.02.006","volume":"35","author":"S Purnell","year":"2017","unstructured":"Purnell S, Sidana A, Maruf M, Grant C, Agarwal PK (2017) Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012). Urol Oncol 35:457.e459-457.e414","journal-title":"Urol Oncol"},{"key":"3443_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"Lenders JWM, Kerstens MN, Amar L et al (2020) Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 38:1443-1456","journal-title":"J Hypertens"},{"key":"3443_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2490-13-22","volume":"13","author":"JA Beilan","year":"2013","unstructured":"Beilan JA, Lawton A, Hajdenberg J, Rosser CJ (2013) Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol 13:22","journal-title":"BMC Urol"},{"key":"3443_CR4","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/j.clgc.2017.03.010","volume":"15","author":"H Zhai","year":"2017","unstructured":"Zhai H, Ma X, Nie W et al (2017) Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center. Clin Genitourin Cancer 15:e765-e771","journal-title":"Clin Genitourin Cancer"},{"key":"3443_CR5","doi-asserted-by":"publisher","first-page":"167.e113","DOI":"10.1016\/j.urolonc.2014.11.017","volume":"33","author":"VL Martucci","year":"2015","unstructured":"Martucci VL, Lorenzo ZG, Weintraub M et al (2015) Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol 33:167.e113-120","journal-title":"Urol Oncol"},{"key":"3443_CR6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM et al (2016) European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174:G1-g10","journal-title":"Eur J Endocrinol"},{"key":"3443_CR7","doi-asserted-by":"publisher","first-page":"354.e359","DOI":"10.1016\/j.urolonc.2019.01.027","volume":"37","author":"H Lu","year":"2019","unstructured":"Lu H, Male M, Jiang K, Ye Z, Song D, Xia D (2019) Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder. Urol Oncol 37:354.e359-354.e317","journal-title":"Urol Oncol"},{"key":"3443_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.12998\/wjcc.v2.i10.591","volume":"2","author":"M Ranaweera","year":"2014","unstructured":"Ranaweera M, Chung E (2014) Bladder paraganglioma: A report of case series and critical review of current literature. World journal of clinical cases 2:591-595","journal-title":"World journal of clinical cases"},{"key":"3443_CR9","doi-asserted-by":"publisher","first-page":"1097149","DOI":"10.1155\/2019\/1097149","volume":"2019","author":"M Male","year":"2019","unstructured":"Male M, Ye T, Tao J, Chen Z-Q, Peng E (2019) Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs. BioMed research international 2019:1097149-1097149","journal-title":"BioMed research international"},{"key":"3443_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.21037\/apm.2020.03.09","volume":"9","author":"J Qin","year":"2020","unstructured":"Qin J, Zhou G, Chen X (2020) Imaging manifestations of bladder paraganglioma. Ann Palliat Med 9:346-351","journal-title":"Ann Palliat Med"},{"key":"3443_CR11","first-page":"2605","volume":"13","author":"J Liang","year":"2016","unstructured":"Liang J, Li H,Gao L, Yin L, Yin L, Zhang J (2016) Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients. Urol J 13:2605-2611","journal-title":"Urol J"},{"key":"3443_CR12","first-page":"311","volume":"49","author":"DG Fan","year":"2020","unstructured":"Fan DG, Wu CL, Huang HJ et al (2020) [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases]. Zhonghua Bing Li Xue Za Zhi 49:311-316","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"3443_CR13","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.ejrad.2010.09.020","volume":"80","author":"H Wang","year":"2011","unstructured":"Wang H, Ye H, Guo A et al (2011) Bladder paraganglioma in adults: MR appearance in four patients. Eur J Radiol 80:e217-220","journal-title":"Eur J Radiol"},{"key":"3443_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.urology.2020.04.098","volume":"143","author":"EY Wang","year":"2020","unstructured":"Wang EY, Pak JS, Virk RK et al (2020) Bladder Preservation for Patients With Bladder Paragangliomas: Case Series and Review of the Literature. Urology 143:194-205","journal-title":"Urology"},{"key":"3443_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1148\/rg.2019180151","volume":"39","author":"SJ Withey","year":"2019","unstructured":"Withey SJ, Perrio S, Christodoulou D et al (2019) Imaging Features of Succinate Dehydrogenase\u2013deficient Pheochromocytoma-Paraganglioma Syndromes. RadioGraphics 39:1393-1410","journal-title":"RadioGraphics"},{"key":"3443_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.urols.2015.05.005","volume":"26","author":"Y-K Chang","year":"2015","unstructured":"Chang Y-K, Chiang IN, Chen C-H et al (2015) Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature. Urological Science 26:111-114","journal-title":"Urological Science"},{"key":"3443_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ultrasmedbio.2013.10.014","volume":"40","author":"Y Li","year":"2014","unstructured":"Li Y, Guo A, Tang J et al (2014) Evaluation of sonographic features for patients with urinary bladder paraganglioma: a comparison with patients with urothelial carcinoma. Ultrasound Med Biol 40:478-484","journal-title":"Ultrasound Med Biol"},{"key":"3443_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1148\/radiol.2017171028","volume":"286","author":"L Huang","year":"2018","unstructured":"Huang L, Kong Q, Liu Z, Wang J, Kang Z, Zhu Y (2018) The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. Radiology 286:502-511","journal-title":"Radiology"},{"key":"3443_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejrad.2017.07.021","volume":"95","author":"S Woo","year":"2017","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2017) Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis. Eur J Radiol 95:46-55","journal-title":"Eur J Radiol"},{"key":"3443_CR20","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00330-008-1073-z","volume":"18","author":"AE Jacques","year":"2008","unstructured":"Jacques AE, Sahdev A, Sandrasagara M et al (2008) Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18:2885-2892","journal-title":"Eur Radiol"},{"key":"3443_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<398::AID-CNCR24>3.0.CO;2-V","volume":"79","author":"CA Moran","year":"1997","unstructured":"Moran CA, Albores-Saavedra J, Wenig BM, Mena H (1997) Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases. Cancer 79:398-402","journal-title":"Cancer"},{"key":"3443_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00383-007-2013-8","volume":"24","author":"JW Mou","year":"2008","unstructured":"Mou JW, Lee KH, Tam YH, Cheung ST, Chan KW, Thakre A (2008) Urinary bladder pheochromocytoma, an extremely rare tumor in children: case report and review of the literature. Pediatr Surg Int 24:479-480","journal-title":"Pediatr Surg Int"},{"key":"3443_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2214\/ajr.168.2.9016215","volume":"168","author":"M Chen","year":"1997","unstructured":"Chen M, Lipson SA, Hricak H (1997) MR imaging evaluation of benign mesenchymal tumors of the urinary bladder. American Journal of Roentgenology 168:399-403","journal-title":"American Journal of Roentgenology"},{"key":"3443_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/rg.262055172","volume":"26","author":"Wong-You\u2013Cheong JJ, Woodward PJ, Ma","year":"2006","unstructured":"Wong-You\u2013Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA (2006) Neoplasms of the Urinary Bladder: Radiologic-Pathologic Correlation. RadioGraphics 26:553-580","journal-title":"RadioGraphics"},{"key":"3443_CR25","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00261-015-0467-z","volume":"40","author":"AD Chung","year":"2015","unstructured":"Chung AD, Schieda N, Flood TA et al (2015) Suburothelial and extrinsic lesions of the urinary bladder: radiologic and pathologic features with emphasis on MR imaging. Abdom Imaging 40:2573-2588","journal-title":"Abdom Imaging"},{"key":"3443_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3348\/kjr.2003.4.2.130","volume":"4","author":"JC Kim","year":"2003","unstructured":"Kim JC, Kim KH, Jung S (2003) Small cell carcinoma of the urinary bladder: CT and MR imaging findings. Korean journal of radiology 4:130-135","journal-title":"Korean journal of radiology"},{"key":"3443_CR27","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1097\/RLU.0000000000002853","volume":"45","author":"LA Parra","year":"2020","unstructured":"Parra LA, Swanson SK, Salomao MA, Yang M (2020) Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake. Clin Nucl Med 45:e156-e157","journal-title":"Clin Nucl Med"},{"key":"3443_CR28","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00259-012-2119-7","volume":"39","author":"JB Maurice","year":"2012","unstructured":"Maurice JB, Troke R, Win Z et al (2012) A comparison of the performance of 68Ga-DOTATATE PET\/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39:1266-1270","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Supplement 1","key":"3443_CR29","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/j.nima.2010.11.092","volume":"648","author":"WW Moses","year":"2011","unstructured":"Moses WW (2011) Fundamental Limits of Spatial Resolution in PET. Nuclear instruments & methods in physics research Section A, Accelerators, spectrometers, detectors and associated equipment 648 Supplement 1:S236-S240","journal-title":"Nuclear instruments & methods in physics research Section A, Accelerators, spectrometers, detectors and associated equipment"},{"key":"3443_CR30","doi-asserted-by":"crossref","unstructured":"Khalil MM, Tremoleda JL, Bayomy TB, Gsell W (2011) Molecular SPECT Imaging: An Overview. International Journal of Molecular Imaging 2011:796025","DOI":"10.1155\/2011\/796025"},{"key":"3443_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","volume":"69","author":"KS Bhatia","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A et al (2008) 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf) 69:181-188","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3443_CR32","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2967\/jnumed.107.047738","volume":"49","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP, Jager PL, Kema IP, Kerstens MN, Albers F, Dullaart RP (2008) 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas. J Nucl Med 49:1232-1237","journal-title":"J Nucl Med"},{"key":"3443_CR33","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K et al (2015) Superiority of [68Ga]-DOTATATE PET\/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res 21:3888-3895","journal-title":"Clin Cancer Res"},{"key":"3443_CR34","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1210\/jc.2011-0333","volume":"96","author":"K King","year":"2011","unstructured":"King K, Chen C, Alexopoulos D et al (2011) Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-d-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. Journal of Clinical Endocrinology and Metabolism 96:2779-2785","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"3443_CR35","doi-asserted-by":"crossref","unstructured":"Wittekind C, Brierley J, Lee A, van Eycken E (2019) TNM Supplement: A Commentary on Uniform Use, 5th Edition edn. Wiley-Blackwell","DOI":"10.1002\/9781119263975"},{"key":"3443_CR36","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. John Wiley & Sons"},{"key":"3443_CR37","unstructured":"Lloyd R, De Lellis R, Heitz P, Eng C (2004) World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs. International Agency for Research on Cancer (IARC) Press, Lyon"},{"key":"3443_CR38","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.clgc.2016.06.006","volume":"15","author":"U Srirangalingam","year":"2017","unstructured":"Srirangalingam U, Banerjee A, Patki P et al (2017) Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas. Clin Genitourin Cancer 15:e131-e136","journal-title":"Clin Genitourin Cancer"},{"key":"3443_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1053\/j.seminoncol.2010.10.017","volume":"37","author":"SMJ Fliedner","year":"2010","unstructured":"Fliedner SMJ, Lehnert H, Pacak K (2010) Metastatic paraganglioma. Seminars in oncology 37:627-637","journal-title":"Seminars in oncology"},{"key":"3443_CR40","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<844::AID-CNCR15>3.0.CO;2-I","volume":"88","author":"L Cheng","year":"2000","unstructured":"Cheng L, Leibovich BC, Cheville JC et al (2000) Paraganglioma of the urinary bladder. Cancer 88:844-852","journal-title":"Cancer"},{"key":"3443_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM et al (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab 96:717-725","journal-title":"J Clin Endocrinol Metab"},{"key":"3443_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.surg.2009.09.013","volume":"146","author":"KA Vanderveen","year":"2009","unstructured":"Vanderveen KA, Thompson SM, Callstrom MR et al (2009) Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery 146:1158-1166","journal-title":"Surgery"},{"key":"3443_CR43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00000539-200003000-00011","volume":"90","author":"MT Sanjoaqu\u00edn","year":"2000","unstructured":"Sanjoaqu\u00edn MT, Fraile JR, Guti\u00e9rrez A, Canal MI, Navia J (2000) Hypertensive crisis during a transurethral resection of the bladder: nondiagnosed bladder paraganglioma. Anesth Analg 90:556-558","journal-title":"Anesth Analg"},{"key":"3443_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39:775-783","journal-title":"Pancreas"},{"key":"3443_CR45","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3892\/etm.2015.2289","volume":"9","author":"C Wang","year":"2015","unstructured":"Wang C, Richmond R, Eldesouki E (2015) Anesthetic management for resection of para-aortic paraganglioma and unexpected aortic resection: A case report. Exp Ther Med 9:1542-1544","journal-title":"Exp Ther Med"},{"key":"3443_CR46","doi-asserted-by":"crossref","unstructured":"Garc\u00eda MIDO, Palas\u00ed R, G\u00f3mez RC, Marco JLP, Merino-Torres JF (2019) Surgical and pharmacological management of functioning pheochromocytoma and paraganglioma. Exon Publications:63\u201380","DOI":"10.15586\/paraganglioma.2019.ch4"},{"key":"3443_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cen.12542","volume":"81","author":"ND Niemeijer","year":"2014","unstructured":"Niemeijer ND, Alblas G, van Hulsteijn LT, Dekkers OM, Corssmit EP (2014) Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf) 81:642-651","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3443_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jso.24553","volume":"115","author":"K Nastos","year":"2017","unstructured":"Nastos K, Cheung VTF, Toumpanakis C et al (2017) Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic\/progressive phaeochromocytomas and paragangliomas. J Surg Oncol 115:425-434","journal-title":"J Surg Oncol"},{"key":"3443_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0031-1301302","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","unstructured":"Gimenez-Roqueplo AP, Dahia PL, Robledo M (2012) An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 44:328-333","journal-title":"Horm Metab Res"},{"key":"3443_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine 17:405-423","journal-title":"Genetics in Medicine"},{"key":"3443_CR51","unstructured":"Ellard S, Baple EL, Berry I et al (2019) ACGS Best Practice Guidelines for Variant Classification 2019,"},{"key":"3443_CR52","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh Q-Y, Eisenhofer G et al (2014) Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 99:1915-1942","journal-title":"The Journal of Clinical Endocrinology & Metabolism"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03443-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T02:06:07Z","timestamp":1666317967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03443-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["3443"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03443-2","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no funding and no conflicts of interest. No patient-identifiable information is used in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}